Comments: US HB3839 | 2023-2024 | 118th Congress

Bill Title: To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.

Spectrum: Bipartisan Bill

Status: (Introduced) 2023-06-09 - Referred to the Subcommittee on Health. [HB3839 Detail]

Text: Latest bill text (Introduced) [PDF]

PolitiCorps Conversations

Start PolitiCorps Debate
TitlePolitiCorpsAccessCommentsViewsLast Post
There are no visible public or private PolitiCorps discussions concerning the 2023 US Congress HB3839 at this time.

Social Comments on US HB3839

feedback